Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 3


Oral and Poster Abstracts Oral 613. Acute Myeloid Leukemia: Clinical and Epidemiological: COVID and beyond Acute Myeloid Malignancies, AML, Non-Biological, Clinical Research, Chemotherapy, Diseases, Real World Evidence, Therapies, Myeloid Malignancies Isla M. Johnson1*, Evandro D. Bezerra, MD2, Faiqa Farrukh, MBBS3*, Kristen McCullough,...

  • 123456 Profile photo of Madelyn

    In a review of 170 AML patients treated at Mayo Clinic with HMA/VEN 20%(!) had a cardiac event, the majority occurred during cycle 1. The most common event was a decrease in the left ventricular ejection fraction. As HMA/VEN use continues to increase in popularity it will be important to keep an eye out for cardiac toxicity.